[1]周寒静,刘静姝,隆姝孜,等.HIF1α特异性人源喉癌噬菌体单链抗体的制备及其对放疗增敏的实验研究[J].第三军医大学学报,2017,39(16):1625-1630.
 ZHOU Hanjing,LIU Jingshu,LONG Shuzi,et al.Preparation of human phage displayed single-chain antibody against hypoxia-inducible factor 1 alpha of laryngeal carcinoma and its effect on radiotherapy sensitization[J].J Third Mil Med Univ,2017,39(16):1625-1630.
点击复制

HIF1α特异性人源喉癌噬菌体单链抗体的制备及其对放疗增敏的实验研究(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
39卷
期数:
2017年第16期
页码:
1625-1630
栏目:
基础医学
出版日期:
2017-08-30

文章信息/Info

Title:
Preparation of human phage displayed single-chain antibody against hypoxia-inducible factor 1 alpha of laryngeal carcinoma and its effect on radiotherapy sensitization
作者:
周寒静刘静姝隆姝孜唐翠萍张涛
重庆医科大学附属第一医院肿瘤科,分子肿瘤及表观遗传学重庆市重点实验室,放射医学与肿瘤研究室
Author(s):
ZHOU Hanjing LIU Jingshu LONG Shuzi TANG Cuiping ZHANG Tao

Department of Oncology, Chongqing Key Laboratory of Molecular Oncology and Epigenetics, Department of Radiation Medicine and Oncology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China

关键词:
噬菌体单链抗体scFv喉癌HIF1&alpha放疗增敏
Keywords:
phage-displayed single-chain variable fragment antibody laryngeal carcinoma hypoxia-inducible factor 1 alpha radiotherapy sensitization
分类号:
R392-33; R392.11; R739.65
文献标志码:
A
摘要:

目的     利用噬菌体肽库技术,构建HIF1α人源喉癌单链抗体(single-chain variable fragment, scFv),研究其对放疗敏感性的影响。方法    提取喉癌患者癌旁阳性淋巴结总RNA,通过RT-PCR和重叠延伸PCR扩增得到可变区基因scFv,将其重组到载体pCANTAB5E中,转化至TG1大肠杆菌,以制备初级抗体库。以HEP2细胞及HIF1α纯化抗原对抗体库进行淘选。SDSPAGE电泳检测scFv的可溶性表达,Western blot检测其对HIF1α蛋白表达的影响,ELISA和细胞免疫化学鉴定其特异性,CCK-8检测scFv联合X线照射后HEP2细胞的存活率,克隆形成实验分析scFv处理后HEP2细胞放疗存活曲线。结果     成功制备HIF1α人源喉癌单链抗体scFv,SDS-PAGE电泳证实其可溶性表达且相对分子质量约为34×103,Western blot表明其能下调HIF1α蛋白的表达。ELISA检测到该抗体对HIF1α抗原的识别率高达79%,细胞免疫化学显示该抗体与HEP2细胞特异性结合。CCK-8检测结果显示scFv联合X线照射后,较单纯X线照射组明显降低了HEP2细胞的存活率(P<0.05),克隆形成实验结果显示scFv对放射的增敏比为1.89。结论     成功构建了HIF1α人源喉癌单链抗体,且其能增加HEP2细胞对放疗的敏感性。
 

Abstract:

Objective     To construct a phage-displayed library and identify phage-displayed single-chain variable fragment (scFv) antibody against hypoxia-inducible factor 1 alpha (HIF1α) of laryngeal carcinoma. Methods      Total RNA of positive lymph node tissues adjacent to laryngeal carcinoma was extracted. ScFv gene fragments were amplified by RT-PCR and splicing-overlap-extension (SOE) PCR, then linked into the pCANTAB5E phagemid vector. The recombinant plasmids were transformed into E.coli TG1 cells in order to create the primary phage-displayed scFv library. The primary scFv library was performed by biopanning against HEP2 cells and HIF1α antigen. The properties of the product were identified by Western blotting, and its specificity was detected by ELISA and immunocytochemical assay. CCK8 assay was used to detect its effect on cell viability, and cell clone assay was used to detect its effect on survival fraction. Results     A phage-displayed scFv library targeting HIF1α antigen and HEP2 cells was successfully constructed. The prepared scFv antibody had an apparent molecular weight of 34×103 and down-regulated the expression of HIF1α protein in HEP2 cells. ELISA showed that the obtained scFv antibody had a positive recognition rate of 79% to HIF1α antigen. Immunocytochemical assay indicated that it could specifically bind to HEP2 cells. The obtained scFv antibody decreased the viability of HEP2 cells after X-ray radiation when compared with the cells treated by radiation alone (P<0.05). Colony formation test showed that the sensitization enhancement ratio (SER) of the antibody to radiation was 1.89. Conclusion    A human anti-HIF1α scFv antibody of laryngeal carcinoma is successfully prepared, and it can increase the radiation sensitivity of HEP2 cells.

参考文献/References:

[1]SUZUKI G, YAMAZAKI H, OGO E, et al. Predisposing Factors for Larynx Preservation Strategies with Nonsurgical Multimodality Treatment for Locally Advanced (T34) Larynx, Hypopharynx and Cervical Esophageal Disease[J]. Anticancer Res, 2014, 34(9): 5205-5210.
[2]SPIELMANN P M, MAJUMDAR S, MORTON R P. Quality of life and functional outcomes in the management of early glottic carcinoma: a systematic review of studies comparing radiotherapy and transoral laser microsurgery[J]. Clin Otolaryngol, 2010, 35(5): 373-382. DOI: 10.1111/ j.1749-4486.2010.02191.x.
[3]LAI S Z, LI W F, CHEN L, et al. How does intensitymodulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?[J]. Int J Radiat Oncol Biol Phys, 2011, 80(3): 661-668. DOI: 10.1016/ j.ijrobp.2010.03.024.
[4]KIM D H, GONG E J, JUNG H Y, et al. Clinical significance of intensive endoscopic screening for synchronous esophageal neoplasm in patients with head and neck squamous cell carcinoma[J]. Scand J Gastroenterol, 2014, 49(12): 1486-1492. DOI: 10.3109/00365521.2013.832369.
[5]SEMENZA G L. Hypoxiainducible factors: mediators of cancer progression and targets for cancer therapy[J]. Trends Pharmacol Sci, 2012, 33(4): 207-214. DOI: 10.1016/ j.tips.2012.01.005.
[6]罗弋, 庞华, 李淑杰, 等. 人源抗PeroxiredoxinⅠ肺腺癌噬菌体抗体的制备及鉴定[J]. 南方医科大学学报, 2010, 36(5): 841-846. DOI:10.13481/j.1671-587x.2010.05.050.
LUO Y, PANG H, LI S J, et al.Preparation and characterization of human phage display antibody against peroxiredoxin I of lung adenocarcinoma[J]. J Southern Med Univ, 2010, 36(5): 841-846. DOI:10.13481/j.1671-587x.2010.05.050. 
[7]ZHAO W S, LUO Y, LI B Y, et al. AntiABCG2 scFv antibody of lung adenocarcinoma increases chemosensitivity and induces apoptosis through the activation of mitochondrial pathway[J]. Am J Cancer Res, 2016, 6(5): 1026-1039.
[8]OVERGAARD J. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck-a systematic review and meta-analysis[J]. Radiother Oncol, 2011, 100(1): 22-32. DOI: 10.1016/j.radonc.2011.03.004.
[9]GODA N, RYAN H E, KHADIVI B, et al. Hypoxiainducible factor 1α is essential for cell cycle arrest during hypoxia[J]. Mol Cell Biol, 2003, 23(1): 359-369. DOI: 10.1128/ MCB.23.1.359369.2003.
[10]HAN S X, ZHU Q, MA J L, et al. Apoptin sensitizes radiationinduced cell death via classic mitochondrial, caspase and p53dependent signaling in HepG2 cells[J]. Mol Med Rep, 2011, 4(1): 59-63. DOI: 10.3892/mmr.2010.391.
[11]OU G, ITASAKA S, ZENG L, et al. Usefulness of HIF-1 imaging for determining optimal timing of combining bevacizumab and radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2009, 75(2): 463-467. DOI: 10.1016/j.ijrobp.2009.02.083.
[12]CHEN G, LI X, YANG J, et al. Prognostic significance of cyclooxygenase-2 expression in patients with hepatocellular carcinoma: a meta-analysis[J]. Arch Med Sci, 2016, 12(5): 1110-1117. DOI: 10.5114/aoms.2016.61916.
[13]DE CECCO L, BOSSI P, LOCATI L, et al. Comprehensive gene expression metaanalysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor[J]. Ann Oncol, 2014, 25(8):1628-1635. DOI: 10.1093/annonc/mdu173.
[14]NELSON A L, DHIMOLEA E, REICHERT J M. Development trends for human monoclonal antibody therapeutics[J]. Nat Rev Drug Discov, 2010, 9(10): 767-774. DOI: 10.1038/nrd3229.
[15]FARAJNIA S, AHMADZADEH V, TANOMAND A, et al. Development trends for generation of single-chain antibody fragments[J]. Immunopharmacol Immunotoxicol, 2014, 36(5): 297-308. DOI: 10.3109/08923973.2014.945126.
[16]QIU Q, WANG Q, DENG C, et al. Small molecular peptide-ScFv αvβ3 conjugates specifically inhibit lung cancer cell growth in vitro and in vivo[J]. Am J Cancer Res, 2016, 6(12): 2846.
[17]PAN X Y, LIU X J, LI J, et al. The ANTITUMOR efficacy of antip21Ras scFv mediated by the dualpromoterregulated recombinant adenovirus KGHV300[J]. Gene Ther, 2017, 24(1): 40-48. DOI:10.1038/gt.2016.74.
[18]MOHAMMADI M, NEJATOLLAHI F, GHASEMI Y, et al. Anti-Metastatic and Anti-Invasion Effects of a Specific AntiMUC18 scFv Antibody on Breast Cancer Cells[J]. Appl Biochem Biotechnol, 2017, 181(1): 379-390. DOI:10.1007/s12010-016-2218-1.
[19]HAN D, WU J, HAN Y, et al. A novel antiPSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer[J]. Oncotarget, 2016, 7(37): 59471-59481. DOI:10.18632/oncotarget.10697.

相似文献/References:

[1]高岭,董明敏,程秀莲.丁酸钠抑制人喉癌裸鼠皮下移植瘤的实验研究[J].第三军医大学学报,2007,29(19):1848.
 GAO Ling,DONG Ming-min,CHENG Xiu-lian.Inhibitory effect of sodium butyrate on human laryngeal carcinoma xenograft model in nude mice[J].J Third Mil Med Univ,2007,29(16):1848.
[2]叶琳,王驰,谢明均,等.粉防己碱对喉癌耐药细胞株Hep-2/ADM多药耐药逆转作用研究[J].第三军医大学学报,2009,31(12):1205.
 YE Lin,WANG Chi,XIE Ming-jun,et al.Reversal effect of tetrandrine on multidrug resistance in laryngeal carcinoma[J].J Third Mil Med Univ,2009,31(16):1205.
[3]李明秀,王建,刘俊,等.喉癌患者术后营养支持[J].第三军医大学学报,2000,22(01):0.[doi:10.16016/j.1000-5404.2000.01.002 ]
[4]刘碾记,黄晋生.喉癌患者血清sIL-2R含量的观察及其意义[J].第三军医大学学报,1999,21(10):0.[doi:10.16016/j.1000-5404.1999.10.009 ]
[5]高代平,王文献.CT在喉癌诊断中的价值(附8例报告)[J].第三军医大学学报,1996,18(02):0.[doi:10.16016/j.1000-5404.1996.02.052 ]
[6]柏露,周建荣,王致娟,等.下调Cyclophilin A对喉鳞癌裸鼠移植瘤模型肿瘤生长和转移的影响[J].第三军医大学学报,2017,39(04):355.
 Bai Lu,Zhou Jianrong,Wang Zhijuan,et al.Effect of cyclophilin A down-regulation on growth and metastasis of laryngeal squamous cell carcinoma in nude mice[J].J Third Mil Med Univ,2017,39(16):355.

更新日期/Last Update: 2017-08-23